HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Mahony, W. B. Articles by Zimmerman, T. P. Search for Related Content PubMed PubMed Citation Articles by Mahony, W. B. Articles by Zimmerman, T. P. Social Bookmarking                      What's this?

J. Biol. Chem., Vol. 263, Issue 19, 9285-9291, Jul, 1988

Acyclovir transport into human erythrocytes

WB Mahony, BA Domin, RT McConnell and TP Zimmerman
Experimental Therapy Department, Wellcome Research Laboratories, Research Triangle Park, North Carolina 27709.

The mechanism of transport of the antiviral agent acyclovir (ACV) into human erythrocytes has been investigated. Initial velocities of ACV influx were determined with an "inhibitor-stop" assay that used papaverine to inhibit ACV influx rapidly and completely. ACV influx was nonconcentrative and appeared to be rate-saturable with a Km of 260 +/- 20 microM (n = 8). However, two lines of evidence indicate that ACV permeates the erythrocyte membrane by means other than the nucleoside transport system: 1) potent inhibitors (1.0 microM) of nucleoside transport (dipyridamole, 6-[(4-nitrobenzyl)thio]-9-beta-D- ribofuranosylpurine, and dilazep) had little (less than 8% inhibition) or no effect upon the influx of 5.0 microM ACV; and 2) a 100-fold molar excess of several purine and pyrimidine nucleosides had no inhibitory effect upon the influx of 1.0 microM ACV. However, ACV transport was inhibited competitively by adenine (Ki = 9.5 microM), guanine (Ki = 25 microM), and hypoxanthine (Ki = 180 microM). Conversely, ACV was a competitive inhibitor (Ki = 240-280 microM) of the transport of adenine (Km = 13 microM), guanine (Km = 37 microM), and hypoxanthine (Km = 180 microM). Desciclovir and ganciclovir, two compounds related structurally to ACV, were also found to be competitive inhibitors of acyclovir influx (Ki = 1.7 and 1.5 mM, respectively). These results indicate that ACV enters human erythrocytes chiefly via the same nucleobase carrier that transports adenine, guanine, and hypoxanthine.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				L. A. Green, K. Nguyen, B. Berenji, M. Iyer, E. Bauer, J. R. Barrio, M. Namavari, N. Satyamurthy, and S. S. Gambhir A Tracer Kinetic Model for 18F-FHBG for Quantitating Herpes Simplex Virus Type 1 Thymidine Kinase Reporter Gene Expression in Living Animals Using PET J. Nucl. Med., September 1, 2004; 45(9): 1560 - 1570. [Abstract] [Full Text] [PDF]

				L. J. M. Wallace, D. Candlish, and H. P. De Koning Different Substrate Recognition Motifs of Human and Trypanosome Nucleobase Transporters. SELECTIVE UPTAKE OF PURINE ANTIMETABOLITES J. Biol. Chem., July 12, 2002; 277(29): 26149 - 26156. [Abstract] [Full Text] [PDF]

				J. Alcorn and P. J. McNamara Acyclovir, Ganciclovir, and Zidovudine Transfer into Rat Milk Antimicrob. Agents Chemother., June 1, 2002; 46(6): 1831 - 1836. [Abstract] [Full Text] [PDF]

				R. B. Tenser, A. Gaydos, and K. A. Hay Inhibition of Herpes Simplex Virus Reactivation by Dipyridamole Antimicrob. Agents Chemother., December 1, 2001; 45(12): 3657 - 3659. [Abstract] [Full Text] [PDF]

				C. B. Washington and K. M. Giacomini Mechanisms of Nucleobase Transport in Rabbit Choroid Plexus J. Biol. Chem., September 29, 1995; 270(39): 22816 - 22819. [Abstract] [Full Text] [PDF]